Since 1991, our company has conducted projects on more than 300 drugs in line and NMEs, most of them first or advance in class.
We also have helped many clients better position some additions to class, generics and biosimilars.
Over the years we have also developed a strong expertise in Diagnostics and Assays, as well as Medical Devices.
SMALL MOLECULES
Our experience with small molecules covers the following:
- TKIs / Targeted therapies (ALK, BRAF, BRCA, CD20, CD30, EGFR, ER, PR, HER-2, KRAS, mRNA…)
- Corticoids, LTRA, SABA, LABA, IC
- ACE inhibitors / AIIAs / ARBs
- DPP4 inhibitors / GLP-1 / SGLT-2
- Statins
- Proton pump inhibitors (PPIs)
- Direct factor Xa inhibitors
- Platelet aggregation inhibitors (P2Y receptors)
- Serotonin-norepinephrine reuptake inhibitor (SNRI)
BIOLOGICS AND PROTEINS
Our experience with biologics focuses on Immunoscience and Immuno-oncology, both on initial drugs and biosimilars. We have conducted projects
in the following fields:
- Monoclonal antibodies (human and chimeric)
- Vaccines,
- Cell or gene therapies,
- Therapeutic protein hormones,
- Cytokines and other signaling proteins
- Tissue growth factors.
MEDICAL DEVICES
We have worked with all the major manufacturers of Medical devices, with a particular focus on the following fields:
- Implants (ocular, orthopedic, cardiovascular)
- Interventional specialty products (radiology, cardiology, neuromodulation, electrophysiology, surgeries)
- Insulin Delivery devices
- Blood Glucose monitors
- Vision care (lenses and glasses)
Our experience in Diagnostics and Assays covers the following fields:
- In Vitro Diagnostics
- Blood screening
- Real time PCR
- Gene expression
- Genome sequencing
- Tissue diagnostics
- MRI and other radiography